COL7A1 and recessive dystrophic epidermolysis bullosa: Castle Creek Biosciences’ D-Fi (debcoemagene autoficel), named FCX-007 prior to Fibrocell Science acquisition, is comprised of autologously-derived fibroblasts from RDEB patients genetically corrected using a lentiviral vector encapsulating the COL7A1 gene.